Middle East & Africa Blood Brain Barrier Technologies Market
The Middle East & Africa Blood Brain Barrier Technologies Market size was valued at US$US$ 43.51 Mn in 2021 and is projected to reach US$ 196.72 Mn by 2028, growing at a CAGR of 24.1% during 2021 - 2028.
Report Coverage
- Technology: Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, Other Non-Invasive BBB Technologies
- Application: Alzheimer's Disease, Epilepsy, Parkinson's Disease, Multiple Sclerosis, Hunter's Syndrome, Brain Cancer
US$US$ 43.51 Mn
Market size in 2021
US$ 196.72 Mn
Market Size by 2028
24.1%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Blood Brain Barrier Technologies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Blood Brain Barrier Technologies Market Regional Analysis
6.2 Middle East & Africa Blood Brain Barrier Technologies Market Revenue 2019-2028 (US$ Million)
6.3 Middle East & Africa Blood Brain Barrier Technologies Market Forecast Analysis
7. Middle East & Africa Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Bispecific Antibody RMT Approach
- 7.1.1 Overview
- 7.1.2 Bispecific Antibody RMT Approach: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Trojan Horse Approach
- 7.2.1 Overview
- 7.2.2 Trojan Horse Approach: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Increasing Permeability
- 7.3.1 Overview
- 7.3.2 Increasing Permeability: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Passive Diffusion
- 7.4.1 Overview
- 7.4.2 Passive Diffusion: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Other Non-Invasive BBB Technologies
- 7.5.1 Overview
- 7.5.2 Other Non-Invasive BBB Technologies: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East & Africa Blood Brain Barrier Technologies Market Analysis – by Application
8.1 Alzheimer's Disease
- 8.1.1 Overview
- 8.1.2 Alzheimer's Disease: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Epilepsy
- 8.2.1 Overview
- 8.2.2 Epilepsy: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Parkinson's Disease
- 8.3.1 Overview
- 8.3.2 Parkinson's Disease: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Multiple Sclerosis
- 8.4.1 Overview
- 8.4.2 Multiple Sclerosis: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Hunter's Syndrome
- 8.5.1 Overview
- 8.5.2 Hunter's Syndrome: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.6 Brain Cancer
- 8.6.1 Overview
- 8.6.2 Brain Cancer: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East & Africa Blood Brain Barrier Technologies Market – Middle East and Africa Analysis
9.1 Overview
9.2 Middle East and Africa- 9.2.1 Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Key Country, 2022 and 2028 (%)
- 9.2.1.1 Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 South Africa: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 South Africa: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.1.2 South Africa: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.2 Saudi Arabia: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Saudi Arabia: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.2.2 Saudi Arabia: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.3 UAE: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 UAE: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.3.2 UAE: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Application
- 9.2.1.4 Rest of Middle East and Africa: Middle East & Africa Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Technology
- 9.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Blood Brain Barrier Technologies Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Eli Lilly and Company
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pfizer, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
